Roche Holding AG Participation

RHHVF.US · Healthcare · Drug Manufacturers - General · USD · Fundamentals
Mixed

Physical assets are 30.2% of total assets, a mixed footprint. Capex is 1.71x depreciation and free cash flow yield is still positive, which fits a physical base that is being replaced or expanded without consuming all of its cash. ROIC is 23.5%, above an 8% cost-of-capital hurdle.

Fixed-asset turnover is 2.76x. Compare it with other names in the same basket.

Physical asset ratio
30.2%
Net PP&E plus inventory, divided by total assets. Above 50% is a heavy footprint.
Fixed asset turnover
2.76x
Revenue per dollar of the physical asset base.
Capex / D&A
1.71x
Above 1.0x means the physical base is being replaced or expanded.
Tangible book / share
$13.91
Assets minus goodwill, intangibles, and liabilities, per share.
Price / tangible book
32.86x
Price $457.03.
Fixed-charge coverage
2.87x
EBITDA minus capex, divided by interest plus short-term debt.
FCF yield
3.6%
Latest free cash flow divided by current market cap ($364.15B).
ROIC
23.5%
After-tax operating income over equity plus debt minus cash. Operating income / net PP&E is 0.81x.

Footprint and return

Turnover and reinvestment

Year Physical FAT Capex/D&A TBV/sh Coverage FCF ROIC EBIT/PP&E
2018 36.2% 2.61x 1.13x $14.14 19.40x $15.06B 47.8% 0.68x
2019 35.4% 2.64x 0.82x $17.59 23.00x $17.49B 50.0% 0.75x
2020 35.4% 2.51x 0.77x $21.69 4.30x $11.88B 32.2% 0.80x
2021 34.8% 2.57x 0.83x $6.34 1.19x $16.43B 29.6% 0.74x
2022 37.2% 2.61x 0.90x $14.40 3.74x $13.86B 27.7% 0.72x
2023 33.9% 2.63x 1.34x $11.35 2.57x $11.45B 25.4% 0.67x
2024 30.8% 2.63x 1.46x $13.78 2.18x $15.09B 16.4% 0.57x
2025 30.2% 2.76x 1.71x $13.91 2.87x $13.07B 23.5% 0.81x
  • Principal due is the current portion of debt.
Latest year inputs (2025)
Net PP&E: $22.93B
Inventory: $7.48B
Total assets: $100.70B
Goodwill: $7.49B
Intangibles: $19.32B
Liabilities: $62.82B
Tangible book: $11.07B
Shares: 795,617,637
Revenue: $63.36B
Capex: $5.78B
D&A: $3.39B
EBITDA: $21.71B
Interest: $1.35B
Short-term debt: $4.21B
Free cash flow: $13.07B
Operating income: $18.48B
Invested capital: $63.93B
Tax rate: 18.7%